Stochastic roadmap simulation for the study of ligand-protein interactions

被引:19
|
作者
Apaydin, MS [1 ]
Guestrin, CE
Varma, C
Brutlag, DL
Latombe, JC
机构
[1] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA
关键词
D O I
10.1093/bioinformatics/18.suppl_2.S18
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Understanding the dynamics of ligand-protein interactions is indispensable in the design of novel therapeutic agents. In this paper, we establish the use of Stochastic Roadmap Simulation (SRS) for the study of ligand-protein interactions through two studies. In our first study, we measure the effects of mutations on the catalytic site of a protein, a process called computational mutagenesis. In our second study, we focus on distinguishing the catalytic site from other putative binding sites. SRS compactly represents many Monte Carlo (MC) simulation paths in a compact graph structure, or roadmap. Furthermore, SRS allows us to analyze all the paths in this roadmap simultaneously. In our application of SRS to the domain of ligand-protein interactions, we consider a new parameter called escape time, the expected number of MC simulation steps required for the ligand to escape from the 'funnel of attraction' of the binding site, as a metric for analyzing such interactions. Although computing escape times would probably be infeasible with MC simulation, these computations can be performed very efficiently with SRS. Our results for six mutant complexes for the first study and seven ligand-protein complexes for the second study, are very promising: In particular, the first results agree well with the biological interpretation of the mutations, while the second results show that escape time is a good metric to distinguish the catalytic site for five out of seven complexes.
引用
收藏
页码:S18 / S26
页数:9
相关论文
共 50 条
  • [1] Predicting ligand-protein interactions
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (07) : 499 - 499
  • [2] Dynamics and thermodynamics of ligand-protein interactions
    Homans, S. W.
    BIOACTIVE CONFORMATION I, 2007, 272 : 51 - 82
  • [3] Ligand-protein interactions in the glutamate receptor
    Jayaraman, V
    Keesey, R
    Madden, DR
    BIOCHEMISTRY, 2000, 39 (30) : 8693 - 8697
  • [4] Ligand-protein interactions in nuclear receptors of hormones
    Egea, PF
    Klaholz, BP
    Moras, D
    FEBS LETTERS, 2000, 476 (1-2) : 62 - 67
  • [5] Ligand-protein interactions in nitric oxide synthase
    Rousseau, DL
    Li, D
    Couture, M
    Yeh, SR
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2005, 99 (01) : 306 - 323
  • [6] Gating, crowding, and intermolecular interactions in ligand-protein association: Modeling with multiscale simulation methods
    Chang, Chia-en A.
    Kang, Myungshim
    Roberts, Christopher
    Cheng, Yuhui
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [7] LigDig: a web server for querying ligand-protein interactions
    Fuller, Jonathan C.
    Martinez, Michael
    Henrich, Stefan
    Stank, Antonia
    Richter, Stefan
    Wade, Rebecca C.
    BIOINFORMATICS, 2015, 31 (07) : 1147 - 1149
  • [8] Alloscore: a method for predicting allosteric ligand-protein interactions
    Li, Shuai
    Shen, Qiancheng
    Su, Minyi
    Liu, Xinyi
    Lu, Shaoyong
    Chen, Zhongjie
    Wang, Renxiao
    Zhang, Jian
    BIOINFORMATICS, 2016, 32 (10) : 1574 - 1576
  • [9] ANALYSIS OF LIGAND-PROTEIN INTERACTIONS BY QUANTITATIVE AFFINITY CHROMATOGRAPHY
    DUNN, BM
    CHAIKEN, IM
    FEDERATION PROCEEDINGS, 1974, 33 (05) : 1388 - 1388
  • [10] ADDITION OF CHEMICAL AND OSMOTIC ENERGIES BY LIGAND-PROTEIN INTERACTIONS
    WEBER, G
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 227 (FEB18) : 486 - 496